NCT00840073View on ClinicalTrials.gov

Trandolapril 4 mg Tablet Under Non-Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions
Healthy
Interventions
DRUG

Trandolapril 4 mg Tablets

1 x 4 mg, single-dose fed

DRUG

Mavik® 4 mg Tablets

1 x 4 mg, single-dose fed

Trial Locations (1)

M1R 5A3

Pharma Medica Research Inc., Toronto

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00840073 - Trandolapril 4 mg Tablet Under Non-Fasting Conditions | Biotech Hunter | Biotech Hunter